Cancer Stem Cells Under Hypoxia As a Chemoresistance Factor in Breast and Brain

Overview

Journal Curr Pathobiol Rep

Specialty Pathology

Date 2014 Mar 4

PMID 24587979

Citations 24

Authors

Spencer W Crowder

Daniel A Balikov

Yu-Shik Hwang

Hak-Joon Sung

Affiliations

Soon will be listed here.

Abstract

Over the last fifteen years, basic science and clinical studies have aimed to identify cancer stem cells (CSCs) in multiple types of cancer in order to unravel their mechanistic roles in cancer recurrence for therapeutic exploitation. Exposure of cells and tissues to hypoxia, or sub-atmospheric concentrations of oxygen (< 21% O), stimulates various stress response pathways that bias the cells towards a self-preserving, anti-apoptotic phenotype. Despite major advances in our understanding of hypoxia, CSCs, and their interrelated nature, some of the most promising cancer therapies have shown limited efficacy in clinic for the past few years, in part due to the inherently hypoxic nature of growing tumors. In the present article, we discuss recent findings regarding the behavior of breast and brain CSCs under hypoxia, as well as the mechanisms that have been shown to drive their chemo-/radioresistance and metastatic potential.

Citing Articles

Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.

Zhi S, Chen C, Huang H, Zhang Z, Zeng F, Zhang S Front Immunol. 2024; 15:1370800.

PMID: 38799423 PMC: 11116789. DOI: 10.3389/fimmu.2024.1370800.

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens.

Srivastava N, Usmani S, Subbarayan R, Saini R, Pandey P Front Oncol. 2023; 13:1199105.

PMID: 37492478 PMC: 10363988. DOI: 10.3389/fonc.2023.1199105.

Molecular pathways in glioblastoma-derived stem cells to identify effective drug agents: A bioinformatics study.

Mirzaei T, Sheikholeslami S, Bereimipour A, Jalili A, Zali A, Sharbati S J Family Med Prim Care. 2022; 11(6):2856-2864.

PMID: 36119333 PMC: 9480797. DOI: 10.4103/jfmpc.jfmpc_1436_21.

Microfluidic Biosensor-Based Devices for Rapid Diagnosis and Effective Anti-cancer Therapeutic Monitoring for Breast Cancer Metastasis.

Sukanya V, Rath S Adv Exp Med Biol. 2022; 1379:319-339.

PMID: 35760998 DOI: 10.1007/978-3-031-04039-9_13.

Tumour Stem Cells in Breast Cancer.

Ibragimova M, Tsyganov M, Litviakov N Int J Mol Sci. 2022; 23(9).

PMID: 35563449 PMC: 9099719. DOI: 10.3390/ijms23095058.

References

Bristow R, Hill R . Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008; 8(3):180-92. DOI: 10.1038/nrc2344. View

Ebos J, Lee C, Cruz-Munoz W, Bjarnason G, Christensen J, Kerbel R . Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009; 15(3):232-9. PMC: 4540346. DOI: 10.1016/j.ccr.2009.01.021. View

Mao X, Xue X, Wang L, Zhang X, Yan M, Tu Y . CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro Oncol. 2013; 15(7):865-79. PMC: 3688011. DOI: 10.1093/neuonc/not029. View

Szot C, Buchanan C, Freeman J, Rylander M . 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials. 2011; 32(31):7905-12. PMC: 3229258. DOI: 10.1016/j.biomaterials.2011.07.001. View

Dewhirst M, Cao Y, Moeller B . Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008; 8(6):425-37. PMC: 3943205. DOI: 10.1038/nrc2397. View

Nayak B, Feliers D, Sudarshan S, Friedrichs W, Day R, New D . Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene. 2012; 32(26):3147-55. PMC: 3696051. DOI: 10.1038/onc.2012.333. View

Krishnamachary B, Penet M, Nimmagadda S, Mironchik Y, Raman V, Solaiyappan M . Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. PLoS One. 2012; 7(8):e44078. PMC: 3429433. DOI: 10.1371/journal.pone.0044078. View

Heddleston J, Wu Q, Rivera M, Minhas S, Lathia J, Sloan A . Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death Differ. 2011; 19(3):428-39. PMC: 3229666. DOI: 10.1038/cdd.2011.109. View

Shrieve D, Harris J . The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers. Int J Radiat Biol Relat Stud Phys Chem Med. 1985; 48(1):127-38. DOI: 10.1080/09553008514551131. View

10.

Lock F, McDonald P, Lou Y, Serrano I, Chafe S, Ostlund C . Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene. 2012; 32(44):5210-9. DOI: 10.1038/onc.2012.550. View

11.

Denko N . Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2009; 8(9):705-13. DOI: 10.1038/nrc2468. View

12.

Zhang L, Hill R . Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion. Cancer Res. 2007; 67(16):7789-97. DOI: 10.1158/0008-5472.CAN-06-4221. View

13.

Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F . Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol. 2003; 162(4):1283-91. PMC: 1851236. DOI: 10.1016/s0002-9440(10)63924-7. View

14.

Churchill-Davidson I, Sanger C, THOMLINSON R . High-pressure oxygen and radiotherapy. Lancet. 1955; 268(6874):1091-5. DOI: 10.1016/s0140-6736(55)90589-4. View

15.

Piao Y, Liang J, Holmes L, Zurita A, Henry V, Heymach J . Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol. 2012; 14(11):1379-92. PMC: 3480262. DOI: 10.1093/neuonc/nos158. View

16.

Kim R, Park J, Roh K, Choi A, Kim S, Kim P . High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Lett. 2012; 333(1):18-31. DOI: 10.1016/j.canlet.2012.11.026. View

17.

Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate K . Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 2000; 19(48):5435-43. DOI: 10.1038/sj.onc.1203938. View

18.

Jordan C, Guzman M, Noble M . Cancer stem cells. N Engl J Med. 2006; 355(12):1253-61. DOI: 10.1056/NEJMra061808. View

19.

Gordan J, Lal P, Dondeti V, Letrero R, Parekh K, Oquendo C . HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell. 2008; 14(6):435-46. PMC: 2621440. DOI: 10.1016/j.ccr.2008.10.016. View

20.

Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M . A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell. 1998; 2(2):259-65. DOI: 10.1016/s1097-2765(00)80137-9. View